English

Quantexa set to achieve $100M in ARR by end of 2024, fueled by the growing Decision Intelligence Market worth *$500BN New enterprise customers accounted for a 20% (+) contribution to fiscal year ARR Closely coupled enterprise Data and AI strategies see Quantexa’s average contract increase 15% in blended ACV in FY24  LONDON and NEW YORK, […]

Geneva, Switzerland / Riyadh, Saudi Arabia – June 5, 2024 – SEALSQ Corp (“SEALSQ” or “Company”) (NASDAQ: LAES), a company that focuses on developing and selling Semiconductors, PKI and Post-Quantum technology hardware and software products, and its parent company, WISeKey, SIX: WIHN; Nasdaq: WKEY), a global leader in cybersecurity, digital identity, and Internet of Things […]

Eanan Al Samma and Jetoptera conduct test flights of subscale J-500 transitioning from vertical to wingborne flight DUBAI, United Arab Emirates and EDMONDS, Wash., June 04, 2024 (GLOBE NEWSWIRE) — We are excited to share the news that Jetoptera and Eanan Al Samma have kicked off the flight test campaign of a subscale, box-wing VTOL […]

IdentiFlight V5 LOUISVILLE, Colo., June 04, 2024 (GLOBE NEWSWIRE) — IdentiFlight, a leader in avian anti-collision systems for wind farms, is proud to announce the launch of its V5 technology. IdentiFlight V5 represents a significant advancement in both performance and reliability. Building upon IdentiFlight’s proven track record of safeguarding avian species while supporting the expansion […]

DURHAM, N.C., June 04, 2024 (GLOBE NEWSWIRE) — Fortrea (Nasdaq: FTRE) a leading global contract research organization (“CRO”), today announced it has completed the divestiture of assets relating to its Enabling Services segment, namely its Endpoint Clinical (“Endpoint”) and Fortrea Patient Access (“FPA”) businesses, to Arsenal Capital Partners (“Arsenal”), a leading private equity firm specializing […]

Mont-Saint-Guibert, Belgium – June 3, 2024, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will participate in the Jefferies Global Healthcare Conference, which takes […]

REGULATED INFORMATION Information on the total number of voting rights and shares Mont-Saint-Guibert (Belgium), June 3, 2024, 10:15 pm CET / 4:15 pm ET –In accordance with article  15 of the Law of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH) publishes the below information following the issue of new shares.  Share capital: EUR 5,902,793.43  Total number […]